[The infant of the diabetic mother. A current reevaluation (author's transl)].
In the past fifteen years several aspects of the diabetogenic fetopathia have changed. Tight metabolic control during pregnancy approaching normoglycemia was followed by a continuous decline in perinatal mortality. However, the evaluation of pregnancy outcome beyond statistical analyses still reveals some pertinent questions: They state to the increased incidence of congenital malformations, the pre- and postnatal diagnosis of significant gestational diabetes, the heterogeneity of impaired intrauterine growth and development and the late outcome of these children.
D000013:Congenital Abnormalities / Q000175:diagnosis*; D005260:Female; D005333:Fetus / Q000502:physiology; D006128:Growth; D006801:Humans; D006932:Hyperbilirubinemia / Q000175:diagnosis; D007226:Infant Mortality; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood; D008297:Male; D009422:Nervous System Diseases / Q000175:diagnosis; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000175:diagnosis*; D011296:Prenatal Diagnosis; D011379:Prognosis; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis
D007328:Insulin
Die diabetogene Fetalkrankheit. Eine aktuelle Bestandsaufnahme.